We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNE icon
576
StoneCo
STNE
$2.53B
$979K 0.03%
28,183
+12,760
+83% +$662K
ARCC icon
577
PUT
Ares Capital
ARCC
$14.3B
$976K 0.03%
48,000
-312,000
-87% -$6.25M
CIEN icon
578
Ciena
CIEN
$56.1B
$975K 0.02%
18,981
-11
-0.1% -$611
COST icon
579
Costco
COST
$421B
$975K 0.02%
+2,169
New +$953K
AAQC
580
DELISTED
Accelerate Acquisition Corp
AAQC
$973K 0.02%
100,000
+1
+0% +$10
HOV icon
581
Hovnanian Enterprises
HOV
$772M
$963K 0.02%
9,987
-4,273
-30% -$427K
UAL icon
582
PUT
United Airlines
UAL
$40.7B
$961K 0.02%
20,200
+200
+1% +$9.42K
UMPQ
583
DELISTED
Umpqua Holdings Corp
UMPQ
$961K 0.02%
47,442
-6,982
-13% -$134K
EAC
584
DELISTED
Edify Acquisition Corp. Class A Common Stock
EAC
$955K 0.02%
97,702
HAE icon
585
Haemonetics
HAE
$3.94B
$943K 0.02%
13,352
-2,341
-15% -$148K
MCHP icon
586
Microchip Technology
MCHP
$44.3B
$940K 0.02%
12,246
-37,780
-76% -$2.83M
XEC
587
DELISTED
CIMAREX ENERGY CO
XEC
$938K 0.02%
10,755
-1,983
-16% -$138K
CLX icon
588
Clorox
CLX
$13B
$936K 0.02%
5,654
+54
+1% +$9.3K
XYZ
589
PUT
Block Inc
XYZ
$47.6B
$935K 0.02%
3,900
BPMC
590
DELISTED
Blueprint Medicines
BPMC
$920K 0.02%
8,951
+1,001
+13% +$93.2K
ITMR
591
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$920K 0.02%
+30,442
New +$673K
BKR icon
592
Baker Hughes
BKR
$63.4B
$918K 0.02%
37,110
+18,478
+99% +$412K
NFH
593
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$916K 0.02%
81,600
HTBK
594
DELISTED
Heritage Commerce
HTBK
$913K 0.02%
+78,515
New +$878K
PRKS icon
595
United Parks & Resorts
PRKS
$2.07B
$909K 0.02%
16,426
-743
-4% -$37.4K
RH icon
596
RH
RH
$3.55B
$906K 0.02%
1,358
-488
-26% -$336K
NEE icon
597
CALL
NextEra Energy
NEE
$176B
$903K 0.02%
11,500
LEGO
598
DELISTED
Legato Merger Corp. Common stock
LEGO
$903K 0.02%
85,880
+7,420
+9% +$79.5K
IRWD icon
599
Ironwood Pharmaceuticals
IRWD
$674M
$899K 0.02%
68,853
-59,014
-46% -$763K
ALNY icon
600
Alnylam Pharmaceuticals
ALNY
$29.2B
$898K 0.02%
4,755
-3,209
-40% -$602K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.